You are here:Home-Chemical Inhibitors & Agonists-Nuclear Receptor/Transcription Factor-Vitamin D Receptor (VDR)-Doxercalciferol
Doxercalciferol

Chemical Structure : Doxercalciferol

CAS No.: 54573-75-0

Doxercalciferol (1alpha-hydroxyvitamin D2; 1alpha-OHD2)

Catalog No.: PC-45806Not For Human Use, Lab Use Only.

A synthetic analog of vitamin D with potential antineoplastic activity.

Packing Price Stock Quantity
5 mg $64 In stock
10 mg $96 In stock
25 mg $216 In stock
50 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

A synthetic analog of vitamin D with potential antineoplastic activity; has also been shown to inhibit the growth of retinoblastomas, and may exhibit some antiproliferative activity against prostate cancer cells.

Hyperparathyroidism

Approved

Physicochemical Properties

M.Wt 412.6478
Formula C28H44O2
Appearance Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

1,3-Cyclohexanediol, 4-methylene-5-[(2E)-2-[(1R,3aS,7aR)-octahydro-7a-methyl-1-[(1R,2E)-1,4,5-trimethyl-2-hexen-1-yl]-4H-inden-4-ylidene]ethylidene]-, (1R,3S,5Z)-

References

1. Attia S, et al. Clin Cancer Res. 2008 Apr 15;14(8):2437-43.

2. Wang YR, et al. Anticancer Res. 2005 Nov-Dec;25(6B):4333-9.

3. Gee J, et al. Prostate. 2013 Jun;73(9):970-8.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: